Minerva Medica

Papers
(The H4-Index of Minerva Medica is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Study on the main types and vaginal microecological status of persistent cervical high-risk human Papillomavirus infection in women of childbearing age76
Efficacy of trastuzumab combined with cisplatin and docetaxel on gastric cardia carcinoma and its influence on HER2 and cyclin D1 expressions49
Neutrophil-to-lymphocyte ratio in bronchoalveolar lavage from IPF patients: a novel prognostic biomarker?36
Effect of psychological intervention combined with family model on postoperative rehabilitation in patients with cervical cancer34
Efficacy evaluation of different conservative treatments for blunt spleen rupture29
Application of diversified nursing mode in clinical nursing of patients with gestational diabetes mellitus23
Measurement of outer nuclear layer and inner/outer segment using spectral-domain optical coherence tomography in patients with diabetic retinopathy22
LncRNA AFAP1-AS1 promotes the metastasis of prostate cancer21
Application and nursing effect analysis of negative pressure wound therapy combined with drip irrigation in the treatment of diabetic refractory wounds20
Hepatic encephalophaty: management and diagnostic therapeutic assistance path of Ligurian Local Health Company 3 (ASL3)19
Impaired endogenous fibrinolysis status: a potential prognostic predictor in ischemic stroke17
Age-related differences in hemodynamics in brain dead donors: effects on liver transplantation in a single center16
Anti-inflammatory role of vitamin D in muscle dysfunctions of patients with chronic obstructive pulmonary disease: a comprehensive review15
AT1R gene polymorphism in coronary heart disease15
Electroacupuncture regulates sperm motility in patients with asthenozoospermia: study protocol for a randomized sham-controlled clinical trial15
Metalloprotease ADAM10 inhibition mitigates acute liver injury via repression of intrahepatic inflammation15
0.21812701225281